Sort
39,280 grants matching “leukemia”
Drug Development of Ribonucleotide Reductase Inhibitor
$334,117David A. Horne · Beckman Research Institute/City Of Hope · R01 · FY2012 · CA
CHEK1 and WEE1 Inhibition as Therapeutic Strategies in AML
$334,116Raoul Tibes · Mayo Clinic Arizona · R01 · FY2014 · CA
Role of Notch and Kidney Development
$334,100Raphael Kopan · Washington University · R01 · FY2008 · DK
Replication of Simple DNA Repeats
$334,085Sergei M. Mirkin · Tufts University Medford · R01 · FY2015 · GM
CDK6 in T cell development and cancer
$334,075Philip W Hinds · Tufts Medical Center · R01 · FY2009 · CA
CDK6 in T cell development and cancer
$334,075Philip W Hinds · Tufts Medical Center · R01 · FY2010 · CA
Signal Transduction by Non-transmembrane PTPs
$334,064Benjamin G. Neel · University Health Network · R37 · FY2011 · CA
Role of PGDH in leukemia pathogenesis
$334,042Michael L Cleary · Stanford University · R01 · FY2016 · CA
Tax regulation of HTLV-I Gene Expression through CBP
$334,033Jennifer K. Nyborg · Colorado State University · R01 · FY2006 · CA
Targeting SYK Kinase in AML
$334,016Kimberly Stegmaier · Brigham And Women'S Hospital · P50 · FY2017 · CA
Mechanisms of retrovirus-induced T and neural cell death
$334,016Paul K Wong · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · MH
Principal Project
$334,000Shiv Subramaniam Pillai · Massachusetts General Hospital · U19 · FY2024 · AI
Drug Resistance in Multiple Myeloma
$334,000William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
Role of TGFBI gene in cell proliferation and tumor progression
$333,954Yongliang Zhao · Columbia University Health Sciences · R01 · FY2010 · CA
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
$333,921Geoffrey L Uy · Washington University · P50 · FY2014 · CA
Megakaryocyte and platelet ontogeny
$333,863James Palis · University Of Rochester · R01 · FY2017 · DK
Function and Regulation of the ETS Transcriptional Repressor Tel-1/YAN
$333,832Ilaria Rebay · University Of Chicago · R01 · FY2016 · GM
Differentiating Agents in Hematologic Malignancies
$333,828Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2009 · CA
Differentiating Agents in Hematologic Malignancies
$333,828Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Differentiating Agents in Hematologic Malignancies
$333,828Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Project 1: Role of HTLV-1 Hbz in Transformation and Disease
$333,790Patrick Lee Green · Ohio State University · P01 · FY2014 · CA
RNA Splicing Modulators for MDS/AML
$333,788Timothy A Graubert · Washington University · P50 · FY2014 · CA
Neurofibromatosis Type 1 Gene Regulates Myelopoiesis
$333,781Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2005 · CA
Expression and Function of Tob in T Lymphocytes
$333,775Massachusetts General Hospital · R01 · FY2005 · CA
Shwachman-Diamond Syndrome: Molecular Pathogenesis
$333,759Akiko Shimamura · Fred Hutchinson Cancer Research Center · R01 · FY2008 · HL